申请人:TAISHO PHARMACEUTICAL CO. LTD
公开号:EP0677293A1
公开(公告)日:1995-10-18
A terpyridine derivative represented by general formula (I) (wherein R represents hydrogen, (un)substituted phenyl, pyridyl, etc.), which has the effect of promoting the production of nerve growth factors or a neurotrophic factor activity. Hence it can be used as an ameliorant or remedy for the symptoms and diseases accompanying peripheral nerve degeneration which is idiopathic or caused by trauma, chemicals such as alcohol or anticancer drug, inflammation, or metabolism as observed in, for example, diabetes. In addition, it can be used as an ameliorant or remedy for the symptoms and diseases accompanying central nerve degeneration, such as senile dementia of Alzheimer type, cerebrovascular dementia, Down's syndrome, Parkinson's disease or Hantington's chorea, mental and motor function incompetences caused by cerebral ischemia, cerebral infarction, cerebral hemorrhage or head injury, spinal neuroparalysis, and so forth.
一种由通式(I)代表的terpyridine衍生物(其中R代表氢、(未)取代的苯基、吡啶基等),具有促进神经生长因子或神经营养因子活性产生的作用。因此,它可作为一种改善剂或治疗剂,用于治疗特发性或由创伤、化学物质(如酒精或抗癌药物)、炎症或代谢(如糖尿病)引起的伴随周围神经变性的症状和疾病。此外,它还可用于改善或治疗中枢神经退化引起的症状和疾病,如阿尔茨海默型老年痴呆、脑血管性痴呆、唐氏综合征、帕金森病或汉廷顿舞蹈症、脑缺血、脑梗塞、脑出血或头部损伤引起的精神和运动功能障碍、脊髓神经麻痹等。